| Restore Mobile Therapy Llc | |
|
6 Logging Trail Ln, Brookfield, CT 06804-1345 | |
| (203) 739-5752 | |
| Not Available |
| Full Name | Restore Mobile Therapy Llc |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 6 Logging Trail Ln, Brookfield, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205451663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Kimberly L Downs |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073740411 PECOS PAC ID: 6608922497 Enrollment ID: I20090921000089 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Provider Name | Kaitlin C Unger |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1437404597 PECOS PAC ID: 9739336348 Enrollment ID: I20120904000096 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Provider Name | Stacey Ann Mcivor |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1508292681 PECOS PAC ID: 0042440596 Enrollment ID: I20140228000297 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Provider Name | Vito Boffoli |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033732680 PECOS PAC ID: 9234525031 Enrollment ID: I20220404002004 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Provider Name | Jenifer Kolwicz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1427435882 PECOS PAC ID: 7214399377 Enrollment ID: I20230822000886 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Provider Name | Stacey Gaudenzi |
|---|---|
| Provider Type | Practitioner - Occupational Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1699880955 PECOS PAC ID: 4385087030 Enrollment ID: I20240209000255 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Restore Mobile Therapy Llc 6 Logging Trail Ln, Brookfield, CT 06804-1345 Ph: (203) 739-5752 | Restore Mobile Therapy Llc 6 Logging Trail Ln, Brookfield, CT 06804-1345 Ph: (203) 739-5752 |
News Archive
A UCLA research study published in the June issue of the American Journal of Geriatric Psychiatry found that people may be able to improve their cognitive function and brain efficiency by making simple lifestyle changes such as incorporating memory exercises, healthy eating, physical fitness and stress reduction into their daily lives.
Type 1 diabetes mellitus contributes to 10% of the total of cases of diabetes mellitus worldwide, mainly in young people and is regarded as a growing health risk.
One thing has become apparent in the ongoing pandemic of COVID-19. Early diagnosis and treatment, when necessary, is crucial to prevent the progression of the disease to critical and life-threatening stages where the mortality rate is much higher than otherwise. Rapid diagnosis is also key to containing outbreaks by allowing for efficient contact tracing in hospitals as well as in communities.
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.
› Verified 3 days ago
Mrs. Kimberly Louise-zipf Downs, MS, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 195 Federal Rd, Suite 6, Brookfield, CT 06804 Phone: 203-546-8648 | |
Grace Elizabeth Englund, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 Ironworks Hill Rd, Brookfield, CT 06804 Phone: 203-725-2041 | |
Mrs. Jill Marie Ropiak, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Black Swan Ct, Brookfield, CT 06804 Phone: 203-775-0131 | |
Ms. Debra A Widman, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 37 Elbow Hill Rd, Brookfield, CT 06804 Phone: 203-376-7341 | |
Ms. Karen Melinda Warhit, O T R Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 777 Federal Rd, Suite 2, Brookfield, CT 06804 Phone: 203-775-0306 Fax: 203-775-3389 | |
Diana Westin, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 13 Windwood Rd, Brookfield, CT 06804 Phone: 845-803-1116 |